Merck, Glenmark Fight Zetia Class Cert. At 4th Circ.
Drugmakers Merck and Glenmark have asked the Fourth Circuit to reverse the class certification of direct buyers of cholesterol drug Zetia, stating the named plaintiffs were unfit to represent the class...To view the full article, register now.
Already a subscriber? Click here to view full article